Helicobacter pylori-Infektion - Klinische Aspekte und Behandlungsindikationen
| Autor: | M. Bischof, Michael Gschwantler, Elisabeth Singer, Werner Weiss |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
medicine.medical_specialty
biology business.industry Atrophic gastritis Autoimmune Gastritis Gastric lymphoma digestive oral and skin physiology Reflux Cancer General Medicine Helicobacter pylori medicine.disease biology.organism_classification Gastroenterology digestive system diseases Internal medicine Medicine Gastritis medicine.symptom business Antrum |
| Zdroj: | Wiener Medizinische Wochenschrift. 152:128-134 |
| ISSN: | 1563-258X 0043-5341 |
| Popis: | Helicobacter pylori (H. p.) causes active chronic antrum gastritis in all infected patients. In a relatively small percentage complications of H. p.-gastritis including duodenal ulcer, gastric ulcer, giant fold gastritis, lymphocytic gastritis, autoimmune gastritis, gastric carcinoma and gastric MALT lymphoma may develop. Strongly recommended indications for eradication therapy include gastroduodenal ulcer disease, giant fold gastritis, lymphocytic gastritis, autoimmune gastritis, gastric MALT lymphoma, atrophic gastritis, corpus-predominant gastritis, post gastric cancer resection and patients who are first degree relatives of gastric cancer patients. Eradication therapy is controversial in patients with gastroesophageal reflux disease, functional dyspepsia and in patients in whom treatment with nonsteroidal antiinflammatory drugs (NSAID) or long-term treatment with proton pump inhibitors (PPI) is planned. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text